Trademark: 79366724
Status Date
Tuesday, March 19, 2024
Filing Date
Monday, March 6, 2023
Published for Opposition
Tuesday, March 12, 2024
5 Pharmaceutical preparations, namely, immunosuppressants, pharmaceutical preparations for the treatment of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases
Mar 19, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2024
Published For Opposition
Feb 28, 2024
Notification Of Notice Of Publication E-Mailed
Feb 28, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 31, 2024
Approved For Pub - Principal Register
Jan 24, 2024
Teas/Email Correspondence Entered
Jan 23, 2024
Correspondence Received In Law Office
Jan 23, 2024
Teas Response To Office Action Received
Jan 2, 2024
Refusal Processed By Ib
Dec 13, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Dec 13, 2023
Refusal Processed By Mpu
Dec 6, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Dec 5, 2023
Non-Final Action Written
Dec 4, 2023
Assigned To Examiner
Apr 14, 2023
Application Filing Receipt Mailed
Apr 10, 2023
New Application Office Supplied Data Entered
Apr 6, 2023
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24